STAHL NEIL
SEC insider (Form 3/4/5 filer). CIK 0001226689. EVP Research and Development at REGENERON PHARMACEUTICALS, INC. (REGN). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 16, 2024. Located in TARRYTOWN, NY.
Companies STAHL NEIL has filed insider reports for
- REGENERON PHARMACEUTICALS, INC. (REGN): Officer, EVP Research and Development
STAHL NEIL
CIK: 0001226689
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REGN
REGENERON PHARMACEUTICALS, INC.
Officer